Elanco Announces FDA Approval and Launch of Zenrelia™ (ilunocitinib tablets), Offering An Effective, Safe Solution in Canine Dermatology
Elanco(ELAN) Prnewswire·2024-09-20 03:08
Itching is one of the top reasons pet owners bring their dog to the veterinarian, and pet owners and veterinarians want more canine dermatology options. Approximately 17 million dogs suffer from allergic skin disease, including atopic dermatitis, food allergies or flea sensitivity2. Among pet owners who say their dog's itch is not under control, 60% say they've tried treating the itch, but nothing works.3 The approval of Zenrelia represents an important advancement in treating itchy dogs suffering from chro ...